Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AJUBA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
H2AFJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBC1D3P1-DHX40P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00643 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RXRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHBDL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEZ6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSSK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4500HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00305 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEX3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on